Department of Biomedical Engineering, Johns Hopkins University, Baltimore, Maryland.
Department of Cardiac Surgery, Division of Cardiac Surgery, Johns Hopkins Hospital, Baltimore, Maryland.
Tissue Eng Part C Methods. 2020 Feb;26(2):80-90. doi: 10.1089/ten.TEC.2019.0228.
A key obstacle in the creation of engineered cardiac tissues of clinically relevant sizes is limited diffusion of oxygen and nutrients. Thus, there is a need for organized vascularization within a three-dimensional (3D) tissue environment. Human induced pluripotent stem cell (hiPSC)-derived early vascular cells (EVCs) have shown to improve organization of vascular networks within hydrogels. We hypothesize that introduction of EVCs into 3D microtissue spheroids will lead to increased microvascular formation and improve spheroid formation. HiPSC-derived cardiomyocytes (CMs) were cocultured with human adult ventricular cardiac fibroblasts (FB) and either human umbilical vein endothelial cells (HUVECs) or hiPSC-derived EVCs for 72 h to form mixed cell spheroids. Three different groups of cell ratios were tested: Group 1 (control) consisted of CM:FB:HUVEC 70:15:15, Group 2 consisted of CM:FB:EVC 70:15:15, and Group 3 consisted of CM:FB:EVC 40:15:45. Vascularization, cell distribution, and cardiac function were investigated. Improved microvasculature was found in EVC spheroids with new morphologies of endothelial organization not found in Group 1 spheroids. CMs were found in a core-shell type distribution in Group 1 spheroids, but more uniformly distributed in EVC spheroids. Contraction rate increased into Group 2 spheroids compared to Group 1 spheroids. The triculture of CM, FB, and EVC within a multicellular cardiac spheroid promotes microvascular formation and cardiac spheroid contraction.
在构建具有临床相关尺寸的工程化心脏组织时,一个关键障碍是氧气和营养物质的扩散有限。因此,需要在三维(3D)组织环境中进行有组织的血管化。人类诱导多能干细胞(hiPSC)衍生的早期血管细胞(EVC)已被证明可以改善水凝胶中血管网络的组织。我们假设将 EVC 引入 3D 微组织球体中,将导致微血管形成增加,并改善球体形成。将 hiPSC 衍生的心肌细胞(CM)与成人心室心脏成纤维细胞(FB)共培养,并与人类脐静脉内皮细胞(HUVEC)或 hiPSC 衍生的 EVC 共培养 72 小时,形成混合细胞球体。测试了三种不同的细胞比例组:第 1 组(对照)由 CM:FB:HUVEC 70:15:15 组成,第 2 组由 CM:FB:EVC 70:15:15 组成,第 3 组由 CM:FB:EVC 40:15:45 组成。研究了血管生成、细胞分布和心脏功能。在 EVC 球体中发现了改善的微血管,其内皮组织形态与第 1 组球体中发现的不同。在第 1 组球体中,CM 位于核心-壳型分布,而在 EVC 球体中分布更均匀。与第 1 组球体相比,第 2 组球体的收缩率增加。在多细胞心脏球体中 CM、FB 和 EVC 的三培养促进了微血管形成和心脏球体收缩。